OH-PARKER-AEROSPACE
Parker Aerospace, a business segment of Parker Hannifin Corporation, the global leader in motion and control technologies, will participate in the HyFIVE consortium of industry and academic partners developing a world-leading liquid hydrogen fuel system and supply chain supporting zero-emission aviation in the 2030s.
In addition to Parker Aerospace, HyFIVE includes fellow industry partners Marshall and GKN Aerospace, as well as academic partners University of Manchester, University of Bath and Cardiff University. The project is supported by the ATI Programme, a partnership between the UK’s Department for Business and Trade, the Aerospace Technology Institute (ATI) and Innovate UK (UKRI). The consortium will receive initial funding of £17 million ($21.5 million) from industry, matched by £20 million ($25 million) from the UK Government.
A path to zero emissions flight
The objective of the HyFIVE consortium is to develop, test and validate a modular and scalable cryogenic hydrogen fuel system architecture appropriate for multiple types of aircraft, and support of hydrogen electric propulsion or hydrogen combustion powertrains. The initiative will address technology development for hydrogen fuel systems in five key areas: storage, conveyance, indication, fueling and venting.
Collaboration among industry leaders
Parker Aerospace, which includes Parker Meggitt, has a broad spectrum of solutions for both airframes and engines and will furnish its advanced technology and expertise in the areas of sensing, thermal management and fluid conveyance.
Marshall will be leading the HyFIVE efforts, providing its expertise in complex system design, integration and certification, honed over decades of delivering aircraft fuel systems and complex aircraft modification projects.
GKN Aerospace, specializing in the design, manufacture and assembly of aircraft structures, engine components and systems, will contribute its industry-leading advanced materials and hydrogen cryogenic system optimization expertise.
Academic partners University of Manchester, University of Bath and Cardiff University have been selected for their world-leading research capabilities and advanced testing facilities in the areas of hydrogen-electric propulsion, cryogenic applications, power transmission, turbomachinery and next-generation material development.
Technical program detailed
The HyFIVE consortium members have defined a full technical program spanning several years, from initial architecture development and supplier engagement to ground testing and final design review for the integrated fuel system.
By 2027, the consortium plans to:
- Develop and validate an integrated family of mature fuel system technologies and capabilities conducive to certification.
- Conduct ground demonstration of an integrated fuel system encompassing the storage, conveyance, indication, venting and fueling systems.
- Open a range of flight demonstration and exploitation paths with prospective customers.
- Develop a customer-ready supply chain and industrialization strategy.
The timely achievement of these objectives will support the successful introduction of a new generation of zero-emissions aircraft in the 2030s.
"Parker is fully committed to sustainability, which is why we are making focused investments in innovative, next-generation technologies,” said Tracy Rice, vice president of technology and innovation for Parker Aerospace. “Hydrogen fuel systems play a critical role in achieving zero emissions in aviation and working with our partners on this project will enable us to further advance our expertise in this area and drive the development of innovative solutions that support a more sustainable future.”
About Parker Aerospace. At Parker Aerospace, we develop technologies and innovative solutions that enable reliable, efficient and increasingly sustainable flight for the lifecycle of the aircraft, including aftermarket support. Parker stands at the forefront of aviation technology with an expanded range of products and services that sits nose-to-tail across the entire aircraft. Our passionate people with deep engineering expertise, together with our breadth of differentiated technologies, ensure that we make the extraordinary happen and continue to shape the future of aviation in partnership with our customers.
About Parker Hannifin. Parker is a Fortune 250 global leader in motion and control technologies. For more than a century the company has been enabling engineering breakthroughs that lead to a better tomorrow. Learn more at www.parker.com or @parkerhannifin.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240424285169/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Murata Begins World’s First Mass Production of 47μF Multilayer Ceramic Capacitor in 0402-inch Size10.7.2025 04:00:00 CEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has begun the world’s first mass production of the 0402-inch size (1.0 × 0.5 mm) multilayer ceramic capacitors (MLCC) with a capacitance of 47μF*. The new product line, available in two variants with different temperature characteristics, is designed to advance MLCC miniaturization and enhance customer system performance. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250709615978/en/ [Murata Manufacturing Co., Ltd.] 47µF MLCC in 0402-inch Size In recent years, high-performance IT solutions, such as those used in AI servers and data centers, have seen rapid growth. Due to the often high component density demanded by these devices, optimized component placement within limited PCB areas is paramount. As a result, there is increasing demand for capacitors that offer both miniaturization and higher capacitance, along with high reliability under high-temperature co
Andersen Consulting udbygger sine kompetencer inden for cybersikkerhed10.7.2025 02:28:00 CEST | Pressemeddelelse
Andersen Consulting fortsætter med at udvikle sine konsulentydelser med samarbejdsfirmaet IT Security Consulting & Training, et rådgivningsfirma inden for informationssikkerhed med hovedkontor i Jordan. IT Security Consulting & Training blev stiftet i 2011 af administrerende partner Muntaser Bdair og har specialiseret sig i at betjene kunder i den statslige, finansielle og industrielle sektor med ekspertise inden for governance, risk og compliance (GRC), tekniske test, administrerede sikkerhedstjenester, databeskyttelse, cyberresiliens og bredere cybersikkerhedsinitiativer. IT Security Consulting & Training samarbejder med organisationer om at vurdere forretnings- og teknologitrusler, implementere robuste kontroller og opretholde overholdelsen af internationale sikkerhedsstandarder. "Vores mission er at give organisationer mulighed for at opnå det højeste niveau af informationssikkerhed gennem praktisk rådgivning, avanceret uddannelse og skræddersyede sikkerhedsløsninger," siger Muntas
Biocytogen Enters into Antibody Licensing Agreement with BeOne Medicines to Accelerate Innovative Drug Development10.7.2025 02:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a global licensing agreement with BeOne Medicines Ltd., a global oncology company, for multiple fully human antibodies. Prior to this licensing agreement, BeOne Medicines had obtained a license to use Biocytogen’s RenMice® fully human antibody platform. Building on this established collaboration, the new agreement expands the partnership into antibody license, further strengthening the strategic relationship between the two companies. Dr. Yuelei Shen, President and CEO of Biocytogen, said, “BeOne Medicines is a global leader in drug development, and we are thrilled to enter into this strategic collaboration. The antibodies licensed under this agreement were discovered using our proprietary RenMice® fully human antibody platform, highlighting o
Andersen Consulting styrker sin tilstedeværelse inden for cybersikkerhed med 10Guards9.7.2025 23:28:00 CEST | Pressemeddelelse
Andersen Consulting udvider sin konsulentkapacitet gennem et samarbejde med 10Guards, en serviceorienteret virksomhed med base i Ukraine, som har specialiseret sig i at levere en bred vifte af professionelle tjenester uden at tilbyde produkter (det være software eller hardware). 10Guards blev stiftet i 2017 og tilbyder skræddersyede cybersikkerhedstjenester, herunder compliance audits, gap assessments og strategisk rådgivning med henblik på at styrke sikkerhedspositionen. De leverer også outsourcet cybersikkerhedssupport gennem virtuelle CISO'er og fulde virtuelle teams, optimering af sikkerhedsdriftscentre (SOC'er) for mere effektiv trusselsdetektering og -respons og etiske hackingtjenester som penetrationstest, social engineering-simuleringer og applikationssikkerhedsvurderinger på tværs af web-, mobil- og cloudmiljøer. "I dagens digitale miljø er cyberresiliens ikke et tilvalg – det er en forudsætning," siger Vitaliy Yakushev, administrerende direktør for 10Guards. "Vores mål er at
IFF to Release Second Quarter 2025 Results on Aug. 5, 20259.7.2025 22:15:00 CEST | Press release
IFF (NYSE:IFF) today announced that it will release its second quarter 2025 earnings results following the market close on Tuesday, Aug. 5, 2025. The management team will host a live webcast on Wednesday, Aug. 6, 2025, at 9:00 a.m. ET to discuss results and outlook with the investor community. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enhancing the human experience.Learn more at iff.com, LinkedIn, Instagram and Facebook. View source version on businesswire.com: https://www.businesswire.com/news/home/20250709408179/en/
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom